Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -90.24%5.91M | 234.39%53.14M | -29,873.08%-7.79M | -137.27%-9.28M | -252.23%-30.15M | 218.49%60.57M | 6,439.09%15.89M | 99.78%-26K | 174.24%24.9M | 443.32%19.81M |
| Net income from continuing operations | -1,238.35%-32.74M | -2,874.73%-27.78M | -333.77%-2.65M | 37.77%-822K | -454.18%-1.48M | 84.11%-2.45M | 88.17%-934K | 93.24%-610K | -235.28%-1.32M | -78.07%419K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -4,119.23%-1.05M | ---1K | ---1.07M | --0 | 525.00%25K |
| Depreciation and amortization | -26.88%487K | 2.59%119K | -32.45%127K | -34.62%119K | -32.22%122K | -4.86%666K | -37.97%116K | 9.30%188K | 18.18%182K | -3.74%180K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Provision for loans, leases and other losses | 35.44%21.92M | 93.45%14.97M | -47.27%2.47M | -44.03%1.88M | 533.33%2.6M | -33.89%16.18M | -6.84%7.74M | -67.56%4.68M | 163.99%3.35M | -11.80%411K |
| Remuneration paid in stock | -99.16%1K | -420.83%-77K | -55.56%28K | 333.33%21K | -29.27%29K | -27.88%119K | 9.09%24K | -13.70%63K | -119.15%-9K | 78.26%41K |
| Deferred tax | 1,485.47%8.96M | 871.17%8.85M | 246.46%343K | 112.50%459K | -471.51%-691K | 94.52%-647K | 85.62%-1.15M | 102.96%99K | 200.00%216K | 134.00%186K |
| Other non cashItems | -85.13%69K | -23.91%70K | -46.15%7K | -101.18%-4K | -119.05%-4K | -55.81%464K | -55.98%92K | -96.01%13K | 924.39%338K | -96.22%21K |
| Change in working capital | -86.55%6.36M | 469.19%56.98M | -107.28%-9M | -148.23%-10.89M | -261.32%-30.73M | 180.78%47.3M | 338.87%10.01M | 69.33%-4.34M | 166.95%22.59M | 394.19%19.05M |
| -Change in receivables | -98.84%564K | 294.00%55.27M | 36.01%-8.64M | -163.62%-16.27M | -232.59%-29.79M | 194.19%48.57M | 336.30%14.03M | -24.44%-13.51M | 172.53%25.58M | 4,430.04%22.47M |
| -Change in payables and accrued expense | -406.15%-1.3M | 883.15%2.84M | -145.42%-2.5M | 226.11%3.44M | -155.08%-5.07M | -68.67%423K | -111.87%-362K | 358.82%5.5M | -184.27%-2.73M | 29.28%-1.99M |
| -Change in other current assets | 509.21%7.02M | 66.90%-1.23M | -39.98%2.2M | 3,778.43%1.88M | 358.27%4.17M | 74.24%-1.72M | -163.36%-3.72M | 481.98%3.67M | 97.29%-51K | 32.93%-1.62M |
| -Change in other working capital | 181.48%76K | 71.67%103K | ---59K | 130.52%65K | -118.33%-33K | 101.60%27K | -43.93%60K | --0 | -223.12%-213K | 110.28%180K |
| Tax refund paid | 2,838.71%849K | 137.50%3K | -7.47%879K | 92.67%-33K | --0 | 99.15%-31K | 97.26%-8K | 272.73%950K | 51.19%-450K | 72.40%-523K |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -90.24%5.91M | 234.39%53.14M | -29,873.08%-7.79M | -137.27%-9.28M | -252.23%-30.15M | 218.49%60.57M | 6,439.09%15.89M | 99.78%-26K | 174.24%24.9M | 443.32%19.81M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.05%-28K | -103.95%-14K | -100.02%-12K | 93.10%-2K | 0 | 25,630.93%60.25M | 3,318.18%354K | 42,924.29%59.95M | 21.62%-29K | 45.83%-26K |
| Net PPE purchase and sale | -100.05%-28K | -100.02%-14K | 93.51%-12K | 93.10%-2K | --0 | 25,630.93%60.25M | 550,036.36%60.49M | -32.14%-185K | 21.62%-29K | 45.83%-26K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.05%-28K | -103.95%-14K | -100.02%-12K | 93.10%-2K | --0 | 25,630.93%60.25M | 3,318.18%354K | 42,924.29%59.95M | 21.62%-29K | 45.83%-26K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 81.64%-19.87M | -541.86%-53.7M | 115.23%9.37M | 107.66%1.51M | 223.44%22.96M | -350.44%-108.17M | -2,497.13%-8.37M | -832.50%-61.48M | -158.33%-19.73M | -3,075.52%-18.6M |
| Net issuance payments of debt | 81.64%-19.87M | -541.86%-53.7M | 115.23%9.37M | 107.66%1.51M | 223.44%22.96M | -339.75%-108.17M | -2,497.13%-8.37M | -780.38%-61.48M | -157.24%-19.73M | -1,567.80%-18.6M |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 81.64%-19.87M | -541.86%-53.7M | 115.23%9.37M | 107.66%1.51M | 223.44%22.96M | -350.44%-108.17M | -2,497.13%-8.37M | -832.50%-61.48M | -158.33%-19.73M | -3,075.52%-18.6M |
| Net cash flow | ||||||||||
| Beginning cash position | 71.97%16.67M | -55.91%6.63M | -52.76%7.55M | -12.60%9.47M | 71.97%16.67M | -46.89%9.7M | 60.56%15.03M | 26.16%15.98M | -16.47%10.84M | -46.89%9.7M |
| Current changes in cash | -210.54%-13.98M | -107.32%-577K | 200.58%1.56M | -251.26%-7.77M | -708.03%-7.19M | 254.99%12.65M | 1,255.94%7.88M | 59.24%-1.55M | 1,906.64%5.14M | 122.79%1.18M |
| Effect of exchange rate changes | 175.78%4.3M | 115.10%941K | -512.81%-2.48M | 584,300.00%5.84M | 80.00%-8K | -1,320.80%-5.67M | -2,453.69%-6.23M | 20.20%601K | 100.18%1K | 54.02%-40K |
| End cash position | -58.08%6.99M | -58.08%6.99M | -55.91%6.63M | -52.76%7.55M | -12.60%9.47M | 71.97%16.67M | 71.97%16.67M | 60.56%15.03M | 26.16%15.98M | -16.47%10.84M |
| Free cash from | -90.22%5.89M | 237.60%53.12M | -3,599.05%-7.81M | -137.32%-9.28M | -252.43%-30.15M | 217.17%60.17M | 6,682.33%15.74M | 98.27%-211K | 174.07%24.87M | 440.04%19.78M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.